About Raffles
Manufacturing partner of choice, for pharma companies from around the globe.
From early stage development to product launch, we support companies around the world.
In addition to the broad variety of molecules we provide, have built focused capabilities in a few select areas. 
Learn more about our existing sites in Guangdong China, and our new manufacturing site in progress.
News and Events
Sharing our experiences with industry events and publications.  
Provide technical data download
Contact Us
Want to connect with someone about a molecule? or looking for your next career opportunity?
Raffles PharmaTech Operations Update

Regarding 2019 nCoV (Coronavirus):

Raffles PharmaTech is located in Huizhou City, Guangdong Province in the far-southern region of China. As of 12:00 on January 31, 2020, 436 cases were confirmed in Guangdong Province, of which 20 cases are confirmed in Huizhou City.
Nationally, the government has implemented a range of measures to control and respond, including isolation of the central province of Hubei, and urgent mobilization of national medical forces to assist those in Hubei. In other provinces, the government has also taken measures to reduce clusters and extend holidays to control the spread of the virus.
As a company, we prioritize the health of employees, and thus far no employees have been infected with the virus. In order to protect the health of employees and increase the effective isolation period, the company's work resumption date was adjusted from January 31, 2020 into February 10, 2020.
We have evaluated the impact of the epidemic on project delivery, and are actively communicating with clients to facilitate arrangements for development and production activities so as to minimize the impact on delivery timelines.
We continue to remain up-to-date with the latest progress of 2019-nCoV, and will start our R&D and production activities as soon as possible, while complying with government regulations and ensuring the health of all the staff.